Three-Dose Pfizer Covid Vaccine Works Safely in Young Children, Review Says
The FDA staff also said, in a review of study data posted online Sunday, that there were no new safety...
Biotechnology
Bristol-Myers to Buy Turning Point Therapeutics for $4.1 Billion
Bristol-Myers Squibb Co. said it will acquire biotechnology company Turning Point Therapeutics Inc. TPTX 116.76% for $4.1 billion, an effort...
Hot Job Market, Strong Demand for CFOs Strain Due Diligence
The sudden exit of Moderna Inc.’s newly hired chief financial officer shines a light on the challenges companies and recruiters...
Moderna Ousts Finance Chief Jorge Gomez in First Week on the Job
On Monday, Jorge Gomez took the reins as the finance chief of the biotech success story Moderna Inc., MRNA -6.29%...
Moderna Seeks to Dismiss Covid-19 Vaccine Patent Lawsuit
Moderna Inc. is trying to fend off rival companies’ claims that its Covid-19 vaccine infringes their patents, arguing that the...
Biotech Stocks, Once Booming, Enter Bear Territory
Biotech companies are having one of their worst stock-market runs in years, as rising interest rates, scientific setbacks and a...
Moderna Beats Profit Estimates, Fueled by Covid-19 Vaccine Sales
Moderna Inc. posted better-than-expected profits for the last three months of 2021 as the company’s Covid-19 vaccine continued to power...
FDA Rejects Short Sellers’ Request to Halt Trials of Alzheimer’s Drug
The Food and Drug Administration has denied a petition by short sellers to halt clinical trials of an experimental Alzheimer’s...
Pfizer Forecasts $54 Billion in 2022 Sales From Its Covid-19 Vaccine, Treatment
As Pfizer Inc. PFE -2.84% forecasts strong sales this year for its Covid-19 vaccine and treatment, the drugmaker is on...
Biogen to Sell Biosimilar-Venture Stake to Partner Samsung Biologics
Biogen Inc. is selling its share in biosimilar joint venture Samsung Bioepis for at least $2.25 billion to partner Samsung...
Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial Patients
Medicare officials said they would cover Biogen Inc.’s BIIB 2.64% controversial Alzheimer’s disease drug Aduhelm on the condition that patients...
CDC Recommends First Covid-19 Boosters for 12- to 15-Year-Olds
The Centers for Disease Control and Prevention recommended Covid-19 boosters for 12- to 15-year-olds, making the doses available to the...
AstraZeneca’s Vaccine, Dumped by the West, Helps Fill Gaping Need in Rest of World
LONDON— AstraZeneca PLC’s Covid-19 vaccine isn’t authorized in the U.S., and governments in Canada, Australia and across Western Europe have...
Moderna Says Covid-19 Booster Dose Works Against Omicron Variant in Lab Tests
Moderna Inc. said a third dose of its Covid-19 vaccine increased immune responses against the Omicron coronavirus variant compared with...
How Blood Samples Are Helping Scientists Test Covid-19 Vaccines Against Omicron
Human blood samples and the substance that makes fireflies glow are among the tools that scientists are using for early...
Glaxo’s Covid-19 Antibody Drug Found to Be Effective Against Omicron
A Covid-19 antibody treatment developed by GlaxoSmithKline PLC and Vir Biotechnology Inc. was effective against the Omicron variant in early...
Covid-19 Boosters From Pfizer-BioNTech, Moderna Cleared for All U.S. Adults
The Food and Drug Administration on Friday cleared Covid-19 boosters from Pfizer Inc. and BioNTech SE and from Moderna Inc....
Pfizer Submits Covid-19 Pill for FDA Authorization
Pfizer Inc. said it asked U.S. health regulators to authorize its oral Covid-19 drug for use in high-risk patients, putting...
Pfizer Says Covid-19 Pill Is 89% Effective in Preliminary Assessment
Pfizer Inc. said a preliminary look at study results found that its experimental pill was highly effective at preventing people...
Pfizer Ups Covid-19 Vaccine Forecast as Sales More Than Double
Pfizer Inc. raised its forecast for sales of its Covid-19 vaccine this year to about $36 billion, a roughly 7%...
